Document is current
Any future updates will be listed below
-
Authors
Chang, Michael
Sherief, Mohamed
Ioannou, Maria
Chinnasamy, Viveka
Chen, Lucy
Frost, Michael
Mattson-Hoss, Michelle
Sarnoff, Herb
Kamson, David O.
Holdhoff, Matthias
Mukherjee, Debraj
Bettegowda, Chetan
Rincon-Torroella, Jordina
Croog, Victoria
Huang, Peng
Rodriguez, Fausto J.
Lucas, Calixto-Hope G.
Schreck, Karisa C. https://orcid.org/0000-0001-7181-3269
-
Funding
Funding for this research was provided by:
DhartSpore (CEP)
National Cancer Institute (P30 CA006973)
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 12 October 2024
First Online: 29 October 2024
Declarations
:
: CB is a consultant for Depuy-Synthe, Bionaut Labs, Haystack Oncology and Privo Technologies. CB is a co-founder of OrisDx and Belay Diagnostics. iNF-07E monoclonal antibody is owned and supplied by Infixion Bioscience, Inc. (San Diego). KCS has received honoraria from Novartis and institutional research funding from Springworks Therapeutics, Pfizer, Lantern Pharma, and FORE Biotherapeutics. She also sits on a data safety and monitoring board for Advarra.
: This study was conducted with the approval of the Johns Hopkins Institutional Review Board (IRB00288357).
: All authors have reviewed and approved the final version of the manuscript and consent to its publication in <i>Acta Neuropathologica Communications.</i>
